An interventional study of Critical care ultrasound in Shock, sponsored by West China Hospital. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-11-01.
Sponsored by West China Hospital · Not applicable, Interventional, and Treatment
Objective
To investigate whether critical care ultrasound oriented shock management in shock patients in intensive care unit(ICU) can improve outcome.
Methods
Randomized controlled research. Patients were randomly allocated to two groups. In the critical care ultrasound oriented shock management group (CUSS group), treatment was oriented by the findings of critical care ultrasound in each shock phase, while in the control group the decisions about the monitoring and management were made by the clinical team. The goal of treatments in both groups were decreasing lactate by 20% or more per 2 hours for the Optimization phase in shock management, and no increase lactate level when removing the fluid in de-escalation phase. The primary outcome measure were hospital mortality and 28-day mortality, the secondary outcome measure were the length of ventilation and the length of ICU stay.
921 studies on the registry are indexed under Shock; 172 are open to participants now.
This study's enrollment of 150 is above the median of 76 across 537 interventional studies indexed under Shock.
Browse Shock studies →West China Hospital is the lead sponsor of 498 studies on the registry; 244 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
usual care
Circulation management will be adjusted according to the results of critical ultrasound combined with clearance of lactic acid in patients with shock.
Other: Critical care ultrasound
Circulateory will be managed according to the result of critical ultrasound joint clearance of lactic acid in patients with shock
28-day mortality
28-day mortality
Time frame: through study completion,an average of 28 days
the length of ICU stay
the length of ICU stay
Time frame: through study completion,an average of 28 days
the total length of hospital stay
the total length of hospital stay
Time frame: through study completion,an average of 28 days
the incidence of AKI
the incidence of AKI
Time frame: through study completion,an average of 28 days
Plan to share: No
This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.